US-based medical technology company Stryker has agreed to acquire care.ai, which offers AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions.
Care.ai’s platform and sensors enable AI-assisted workflows that can help deliver a responsive and personalised healthcare environment, allowing caregivers to spend more time with patients.
Stryker said the acquisition will add care.ai’s complementary technology that can be easily integrated with its Vocera clinical communication and workflow platform and other devices.
In addition, the technology helps provide customers with an ecosystem that can deliver dynamic clinical workflows and further the development of smart care facilities.
The closing of the proposed acquisition is subject to certain customary closing conditions.
Stryker and care.ai will operate as separate entities and continue with their business operations as usual, until the transaction is completed.
Stryker Group MedSurg and neurotechnology president Andy Pierce said: “This acquisition underscores our commitment and focus on our customers.
“care.ai will help Stryker significantly accelerate our healthcare IT and digital vision to provide customers with real-time, smart and connected decision-making tools that enhance the lives of caregivers and their patients.”
According to Stryker, customers continue to face nursing shortages, employee retention challenges, overworked and cognitively burdened staff, and a rise in workplace safety concerns.
The proposed acquisition will strengthen its growing healthcare IT offering and portfolio of wirelessly connected medical devices, said the medical technology company.
In June this year, Stryker agreed to acquire Artelon, a US-based developer of soft tissue fixation products designed for foot and ankle and sports medicine procedures, for an undisclosed sum.
Artelon, through its FLEXBAND Twist, FLEXBAND Solo, FLEXBAND Multi, and FLEXBAND FIX systems, offers tools and implants in a single-use, sterile blister, targeting specific indications.
Recently, Stryker completed the acquisition of MOLLI Surgical, a company that develops wire-free soft tissue localisation technology for breast-conserving surgery.
